Redoxis attended the BioEurope spring partnering meeting in Barcelona 20-22 March. During this successful event we enjoyed meetings with new partners and potential collaborators. For a PFD with our brief overview of models and services, send us an email with your request to email@example.com
Friday the 20th of January, Medicon Village hosted a large event to celebrate their first 5-years. Their success have been enormous and plans for the future are even greater. Read more here Medicon village 5-year celebration. Redoxis was present at the exhibition together with many other companies from Medicon Village.
The electronic version of our manuscript “Cytokine correlation analysis based on drug perturbation” was recently accepted published after acceptance into the journal Cytokines. In the manuscript, our rat ex vivo assay is used to investigate cytokine response to various anti-inflammatory drugs. Read more here
Redoxis will, as a part of a delegation of innovative life science companies from Skåne, together with Invest in Skåne participate in the partnering meeting BioEurope in Cologne 7-9 November. Contact us for a meeting and presentation on our models and services and suggestion on how we can bring more value to your preclinical projects. […]
Innovative Medicines Initiative BTCure, in which Redoxis is a partner, has combined experience from laboratories worldwide to establish standardised protocols for animal models of Rheumatoid Arthritis. Recently, a paper describing the Pristane Induced Arthritis (PIA) model was published in PLOS ONE. PIA in rats is a highly reproducible models suggest to reflect the early events […]